about
Rituximab leads to long remissions in patients with chronic immune thrombocytopeniaAccuracy of Platelet Counting by Optical and Impedance Methods in Patients with Thrombocytopaenia and Microcytosis.Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic LeukemiaAetiological profile of women presenting with premature ovarian failure to a single tertiary care center in Oman.Biclonal Gammopathy in Chronic Lymphocytic Leukemia: Case Report and Review of the Literature.Mode of delivery and risk of intracranial haemorrhage in newborns with severe haemophilia A: a multicentre study in Gulf region.Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation groEpidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman.First Implementation of Transfusion Consent Policy in Oman: Audit of compliance from a tertiary care university hospital.Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.Alloimmunization in Patients with Sickle Cell Disease and Thalassemia: Experience of a Single Centre in Oman.Clinical and molecular findings of chronic granulomatous disease in Oman: family studies.Regulatory B Cells Are Functionally Impaired in Patients Having Hemophilia A With Inhibitors.First Cytogenetic Profile of Omani Patients with de novo Myelodysplastic Syndromes: Comparison with data from Asia, Africa, Europe and North and South America.Impact of Educational Activities in Reducing Pre-Analytical Laboratory Errors: A quality initiative.Therapeutic drug monitoring-guided dosing of busulfan differs from weight-based dosing in hematopoietic stem cell transplant patients.Haemoglobin Fontainebleau (HBA2: c. 64G>C) in Oman: molecular and haematological characteristics and interaction with various haemoglobinopathies.The pneumatic tube system does not affect complete blood count results; a validation study at a tertiary care hospital.A stepwise α-thalassemia screening strategy in high-prevalence areas.A novel p.Pro353His SERPINC1 mutation in the thrombin-binding region affecting stability of Antithrombin molecule in an extended Omani family.Stability of fetal hemoglobin levels in patients receiving metformin therapy.THE USE OF HPLC AS A TOOL FOR NEONATAL CORD BLOOD SCREENING OF HAEMOGLOBINOPATHY - A VALIDATION STUDYWorldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic ConsiderationsIdiopathic thrombocytopenic purpura and hypokalaemic dRTA with compensated haemolysis and striking acanthocytosis in a band 3 (SLC4A1/AE1) A858D homozygotePredictors of impending acute chest syndrome in patients with sickle cell anaemiaCan Gestational Anemia be Alleviated with Increased Awareness of its Causes and Management Strategies? Implications for Health Care ServicesPhysical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) GroupPrevalence of Hepatitis B, Hepatitis C, and HIV in Multiply Transfused Sickle Cell Disease Patients from OmanClinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patientsEfficiency of day 4 compared to day 6 stem cell mobilization in allogeneic stem cell donors
P50
Q33422731-1F7BC564-1E0C-4FAA-90BD-E2B0EADE83C4Q33428080-5D4AD538-5FE3-4A96-87B3-F91E3E7489A0Q33736847-58236ACE-D254-446E-B263-AACDF05402C2Q38495965-27B8D418-EFC2-4318-ACF3-2EB37C90AED3Q38546557-1D41CFBB-F9EB-446B-88FF-7A66EC7AA46CQ38561079-A2BB1BDA-3399-471B-8943-F4FA1EE4FF6BQ38954938-EDC70363-DE24-47AC-B074-DBA0F0C9F5E4Q39400593-D4C58B14-649C-4CFE-B104-49A73A5FE0D3Q40232363-199A4FFE-FAA0-4069-9E76-D849185BCCFCQ41271261-095C3C83-FCA5-40C7-B376-DAF3E1B44D22Q41878174-B3E17995-8AD4-48D1-8DEB-CF720251BCC6Q41948001-2B4F5EE8-A02D-45C4-86D6-E7E58FD538E5Q43448908-09C898ED-7A1C-43FD-952F-80FEC5E04D2AQ45866611-E2F48F1B-5EA5-466D-A180-BA3CA4251134Q47132050-0C016070-72F5-4F2A-A0EF-6BA884E3EC20Q47140706-5C2E65DC-67FF-49B7-9358-A4A021339B37Q47220775-5CE4EF03-0217-4CCB-BECB-B811B19E1141Q47302726-FC2ABA0F-9F73-4F02-9DC0-F11655BEEB13Q50481685-16A88EAA-D5F0-4201-95EA-00A76AB5F80FQ50998515-C252CB5A-34F2-4D63-BA85-06EF7AD4C724Q52630928-1071DEDE-D572-491C-B08D-84FFA137E656Q53688953-7462D506-CCA8-492B-BBD6-189CC6389749Q60923185-6949F22C-3202-438A-BEA2-7AA5C6819EADQ64110776-18850E4A-419E-4AD8-8100-5E2BDA9634E4Q87423506-EEA8D908-CA26-4B24-808A-C88E20BA9F3CQ89686505-2BC7B504-21AA-4A7F-997F-E70A48DD41DBQ90430768-F8626101-471E-428C-BC1E-86AD46FE1C28Q91091231-8C9B5CC5-AE61-458D-91F6-A779AF420319Q91176263-715E396C-AD95-47E1-87D3-CA821455E6C1Q91762769-08B00601-D846-41B6-9CA2-F57CE557F4F8Q92710111-80FCE4C4-A35B-428A-BC10-494CFBF69D3D
P50
description
researcher
@en
wetenschapper
@nl
name
Salam Salim Amur Alkindi
@en
Salam Salim Amur Alkindi
@nl
type
label
Salam Salim Amur Alkindi
@en
Salam Salim Amur Alkindi
@nl
prefLabel
Salam Salim Amur Alkindi
@en
Salam Salim Amur Alkindi
@nl
P31
P496
0000-0001-6863-5748